Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; Acute coronary syndrome; Thrombin activatable fibrinolysis inhibitor; Proinflammatory cytokine; Acute phase protein; Coronary disease; SÃndrome coronario agudo; Inhibidor de la fibrinólisis activado por trombina; Citocina proinflamatoria; ProteÃna de l
مقالات ISI مهار کننده فیبرینولیز فعال فعال ترومبین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; Acute coronary syndrome; Thrombin activatable fibrinolysis inhibitor; Proinflammatory cytokine; Acute phase protein; Coronary disease; SÃndrome coronario agudo; Inhibidor de la fibrinólisis activado por trombina; Citocina proinflamatoria; ProteÃna de l
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; CVD; cardiovascular disease; USDA; United States Department of Agriculture; MUFA; monounsaturated fatty acids; GI; glycaemic index; MUFObes; Mono Unsaturated Fatty acids in Obesity; LF; low-fat; BMI; body mass index; FVII; factor VII; TAFI; thrombin activ
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; fibrin clot; fibrinolysis; hyperthyroidism; hypothyroidism; thrombin activatable fibrinolysis inhibitor; TAFI;
Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; Anticoagulants; Coagulation; Fibrinolysis; Thrombin; Thrombin activatable fibrinolysis inhibitor;
Haplotypes of TAFI gene and the risk of cerebral venous thrombosis - a case-control study
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; CVT; cerebral venous thrombosis; DVT; deep vein thrombosis; PE; pulmonary embolism; TAFI; thrombin-activatable fibrinolysis inhibitor; SNP; single nucleotide polymorphism; VTE; venous thromboembolism; OR; odds ratio; CI; confidence interval; OC; oral cont
Regular ArticleThe alpha-2-antiplasmin Arg407Lys polymorphism is associated with Abdominal Aortic Aneurysm
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; AAA; Abdominal Aortic Aneurysm; α2AP; alpha 2 antiplasmin; DNA; deoxyribonucleic acid; ILT; Intra-luminal thrombus; LEADS; Leeds Aneurysm Development Study; TAFI; Thrombin activatable fibrinolysis inhibitor; tPA; tissue plasminogen activator; Alpha-2-ant
The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; AT; antithrombin; AUC; area under the curve; DMSO; dimethyl sulfoxide; αPC; monoclonal antibody against human protein C; DTIs; direct thrombin inhibitors; ETP; endogenous thrombin potential; PC; protein C; PTCI; potato tuber carboxypeptidase inhibitor; r
Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; CPB; carboxypeptidase B; CPN; carboxypeptidase N; TAFI; thrombin activatable fibrinolysis inhibitor; tPA; tissue-type plasminogen activator; Carboxypeptidase; Fibrin; Fibrinolysis; Plasmin; tPA;
Thrombomodulin-dependent effect of factor VLeiden mutation on factor XIII activation
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; α2-PI; α2-plasmin inhibitor; APC; activated protein C; FVa; activated factor V; FVLeiden; factor V Leiden mutation; FXIII; factor XIII; FXIIIa; active factor XIII; FXIII-A; factor XIII A subunit; FXIII-A'; proteolytically activated factor XIII A subun
Comparative evaluation of Tissue factor and Thrombomodulin activity changes during normal and idiopathic early and late foetal loss: The cause of hypercoagulability?
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; TF; Tissue Factor; TFa; Tissue Factor activity; TM; Thrombomodulin; TMa; Thrombomodulin activity; PPL; Procoagulant phospholipids; TAFI; Thrombin activatable fibrinolysis inhibitor; PC; Protein C; EPCR; Endothelial PC receptor; sEPCR; soluble form of EPCR
Global haemostasis assays, from bench to bedside
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; α; angle that assesses rate of clot formation; α2M; α2-macroglobulin; AMC; 7-amino-4-methylcoumarine; AT; antithrombin; AUC; area under the curve; APC; activated protein C; aPTT; activated partial thromboplastin time; A10; the amplitude after ten minut
Is complement a culprit in infection-induced forms of haemolytic uraemic syndrome?
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; HUS; haemolytic uraemic syndrome; TMA; thrombotic microangiopathy; ECs; endothelial cells; AP; alternative pathway; CP; classical pathway; MAC; membrane attack complex; CFH; complement factor H; SCRs; short consensus repeats; CFI; complement factor I; DAF
Liporetro-D-peptides - A novel class of highly selective thrombin inhibitors
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; DCC; N N'dicyclohexylcarbodiimide; DMF; dimethyl formamide; DMSO; dimethyl sulfoxide; HRMS; high resolution mass spectra; LDI; laser desorption ionization; PEG; polyethylene glycol; TAFI; thrombin activatable fibrinolysis inhibitor; TLC; thin layer chroma
Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; TAFI; Thrombin activatable fibrinolysis inhibitor; TAFIa; Thrombin activatable fibrinolysis inhibitor activate; PCR-RT; Polymerase chain reaction- Real time; DNA; Deoxyribonucleic acid; OR; Odds ratio; Thrombin-activated fibrinolysis inhibitor (TAFI); Car
High thrombin activatable fibrinolysis inhibitor levels are associated with an increased risk of premature peripheral arterial disease
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; Thrombin activatable fibrinolysis inhibitor; Fibrinolysis; Peripheral arterial disease; Arterial thrombosis;
Oxygenated analogues of UK-396082 as inhibitors of activated thrombin activatable fibrinolysis inhibitor
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; Thrombin activatable fibrinolysis inhibitor; TAFI; Carboxypeptidase U; Carboxypeptidase inhibitors
Coagulation-Fibrinolysis Changes During Off-Pump Bypass: Effect of Two Heparin Doses
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; ACT; activated clotting time; CABG; coronary artery bypass graft surgery; CPB; cardiopulmonary bypass; F1+2; prothrombin fragment 1+2; OPCABG; off-pump coronary artery bypass graft surgery; PAP; plasmin-antiplasmin complex; PFA; platelet function analyzer
Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; Preeclampsia; Antiphospholipid syndrome; Antiphospholipid antibodies; Clot lysis time; Pregnancy; Thrombin activatable fibrinolysis inhibitor
In vitro effects of detergent sclerosants on fibrinolytic enzymes and inhibitors
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; Detergent sclerosants; Fibrinolysis; Plasminogen; Tissue plasminogen activator; Plasminogen activator inhibitor; Thrombin activatable fibrinolysis inhibitor
Valor pronóstico de la concentración del inhibidor de la fibrinolisis activable por trombina y del polimorfismo C1040T en el infarto agudo de miocardio tratado con fibrinolisis
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; Enfermedad coronaria; Fibrinolisis; Infarto agudo de miocardio; Inhibidor de la fibrinolisis activable por trombinaCoronary disease; Fibrinolysis; Acute myocardial infarction; Thrombin activatable fibrinolysis inhibitor
Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; FV Leiden; Factor V Leiden; proCPU; procarboxypeptidase U; CPU; carboxypeptidase U; TAFI; Thrombin Activatable Fibrinolysis Inhibitor; TAFIa; activated Thrombin Activatable Fibrinolysis Inhibitor; IIa; thrombin; TM; thrombomodulin; PPACK; D-phenylalanyl-L
Plasma activity of thrombin activatable fibrinolysis inhibitor in Crimean-Congo hemorrhagic fever
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; Thrombin activatable fibrinolysis inhibitor; Crimean-Congo hemorrhagic fever
Changes in coagulation-fibrinolysis balance in blood mononuclear cells and in gastric mucosa from patients with Helicobacter pylori infection
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; MNC; mononuclear cells; TF; tissue factor; PAI-2 and PAI-1; plasminogen activator inhibitor type 2 and type 1; TM; thrombomodulin; HP-NAP; H. pylori neutrophil-activating protein; TAFI; thrombin activatable fibrinolysis inhibitor; t-PA; tissue plasminogen
Effects of TNF-α and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; TNF-α; tumor necrosis factor-alpha; TM; thrombomodulin; EPCR; endothelial protein C receptor; HUVECs; Human umbilical vein endothelial cells; IL-1; interleukin-1; TF; tissue factor; PAI-1; plasminogen activator inhibitor type-1; tPA; tissue-type plasmino
Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature
Keywords: مهار کننده فیبرینولیز فعال فعال ترومبین; APC; activated protein C; aPTT; activated partial thromboplastin time; AT; antithrombin; BMI; body mass index; CEE; conjugated equine estrogen; DVT; deep vein thrombosis; HERS; Heart and Estrogen/Progestin Replacement Study; E2; estradiol; ET; estrogen th